title: Response of substances co-expressed in hypothalamic magnocellular neurons to osmotic challenges in normal and Brattleboro rats.
abstract: The intention of this review is to emphasize the current knowledge about the extent and importance of the substances co-localized with magnocellular arginine vasopressin (AVP) and oxytocin (OXY) as potential candidates for the gradual clarification of their actual role in the regulation of hydromineral homeostasis. Maintenance of the body hydromineral balance depends on the coordinated action of principal biologically active compounds, AVP and OXY, synthesized in the hypothalamic supraoptic and paraventricular nuclei. However, on the regulation of water-salt balance, other substances, co-localized with the principal neuropetides, participate. These can be classified as (1) peptides co-localized with AVP or OXY with unambiguous osmotic function, including angiotensin II, apelin, corticotropin releasing hormone, and galanin and (2) peptides co-localized with AVP or OXY with an unknown role in osmotic regulation, including cholecystokinin, chromogranin/secretogranin, dynorphin, endothelin-1, enkephalin, ferritin protein, interleukin 6, kininogen, neurokinin B, neuropeptide Y, vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, TAFA5 protein, thyrotropin releasing hormone, tyrosine hydroxylase, and urocortin. In this brief review, also the responses of these substances to different hyperosmotic and hypoosmotic challenges are pointed out. Based on the literature data published recently, the functional implication of the majority of co-localized substances is still better understood in non-osmotic than osmotic functional circuits. Brattleboro strain of rats that does not express functional vasopressin was also included in this review. These animals suffer from chronic hypernatremia and hyperosmolality, accompanied by sustained increase in OXY mRNA in PVN and SON and OXY levels in plasma. They represent an important model of animals with constantly sustained osmolality, which in the future, will be utilizable for revealing the physiological importance of biologically active substances co-expressed with AVP and OXY, involved in the regulation of plasma osmolality.
authors.affiliation: Laboratory of Functional Neuromorphology, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia.
authors.forename: Jana
authors.initials: J
authors.lastname: Bundzikova
authors.forename: Zdeno
authors.initials: Z
authors.lastname: Pirnik
authors.forename: Dora
authors.initials: D
authors.lastname: Zelena
authors.forename: Jens D
authors.initials: JD
authors.lastname: Mikkelsen
authors.forename: Alexander
authors.initials: A
authors.lastname: Kiss
mesh_terms: D000818:Animals; D007031:Hypothalamus / Q000378:metabolism* / Q000503:physiopathology; D009474:Neurons / Q000378:metabolism*; D009479:Neuropeptides / Q000378:metabolism*; D009995:Osmosis; D051381:Rats; D011910:Rats, Brattleboro; D014882:Water-Electrolyte Balance / Q000502:physiology
chemical_list: D009479:Neuropeptides
references.citation: Neuroendocrinology. 1993 Jun;57(6):1035-41
references.pmid: 8232762
references.citation: Ann N Y Acad Sci. 1998 Dec 21;863:305-22
references.pmid: 9928180
references.citation: Mass Spectrom Rev. 2002 Jul-Aug;21(4):220-43
references.pmid: 12533798
references.citation: Fed Proc. 1985 Jan;44(1 Pt 2):259-63
references.pmid: 3871412
references.citation: Neurosci Lett. 1997 Jun 20;229(1):65-8
references.pmid: 9224803
references.citation: Crit Care Med. 2008 Jan;36(1 Suppl):S9-16
references.pmid: 18158483
references.citation: Cell Tissue Res. 1976 Jan 27;165(3):307-16
references.pmid: 1248028
references.citation: Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):1003-10
references.pmid: 16802191
references.citation: Neuroendocrinology. 1985 Jan;40(1):2-24
references.pmid: 3969196
references.citation: J Physiol Pharmacol. 1995 Jun;46(2):169-77
references.pmid: 7670125
references.citation: Trends Endocrinol Metab. 1998 Oct 1;9(8):329-36
references.pmid: 18406298
references.citation: J Physiol Pharmacol. 2005 Dec;56(4):673-88
references.pmid: 16391423
references.citation: Endocr Regul. 2005 Sep;39(3):97-105
references.pmid: 16468232
references.citation: Brain Res. 2008 Mar 14;1199:1-9
references.pmid: 18275939
references.citation: J Endocrinol. 1991 Apr;129(1):49-54
references.pmid: 2030328
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2001 May;25(4):729-41
references.pmid: 11383975
references.citation: Endocrinology. 1993 Feb;132(2):530-3
references.pmid: 8425473
references.citation: Brain Res. 1992 Jul 17;586(1):111-6
references.pmid: 1511340
references.citation: Genes Chromosomes Cancer. 2005 Oct;44(2):161-9
references.pmid: 15945096
references.citation: Front Biosci. 2005 Jan 01;10:216-35
references.pmid: 15574363
references.citation: Horm Metab Res. 1996 Jun;28(6):257-66
references.pmid: 8811325
references.citation: Histochemistry. 1991;96(3):229-43
references.pmid: 1917578
references.citation: Neuroreport. 1996 Dec 20;8(1):67-70
references.pmid: 9051754
references.citation: J Neurosci. 1983 Jul;3(7):1355-68
references.pmid: 6345725
references.citation: Endocrinology. 2006 Sep;147(9):4122-31
references.pmid: 16728491
references.citation: Cell Mol Neurobiol. 2007 Jun;27(4):439-61
references.pmid: 17318384
references.citation: Am J Physiol Regul Integr Comp Physiol. 2006 May;290(5):R1251-61
references.pmid: 16306162
references.citation: Cell Tissue Res. 1989 Jan;255(1):139-47
references.pmid: 2472216
references.citation: Neurosci Lett. 1998 May 29;248(2):144-6
references.pmid: 9654364
references.citation: Neurosci Lett. 1980 Oct 20;20(1):85-8
references.pmid: 6133255
references.citation: Cell Tissue Res. 1981;221(1):227-31
references.pmid: 7032704
references.citation: Regul Pept. 1989 Jan;24(1):81-6
references.pmid: 2472648
references.citation: J Neuroendocrinol. 1996 Jun;8(6):417-25
references.pmid: 8809671
references.citation: Brain Res Dev Brain Res. 1994 Nov 18;83(1):59-66
references.pmid: 7697871
references.citation: Science. 1982 Apr 2;216(4541):85-7
references.pmid: 6121376
references.citation: Anesthesiology. 2006 Sep;105(3):599-612; quiz 639-40
references.pmid: 16931995
references.citation: Eur J Neurosci. 1996 May;8(5):988-1000
references.pmid: 8743747
references.citation: Endocrinology. 1988 Nov;123(5):2249-54
references.pmid: 3168920
references.citation: Exp Brain Res. 1979 Apr 2;35(2):315-31
references.pmid: 86456
references.citation: Curr Med Chem. 2004 Aug;11(15):2045-81
references.pmid: 15279567
references.citation: J Comp Neurol. 1988 Jul 1;273(1):87-98
references.pmid: 3062045
references.citation: Neurosci Lett. 1990 Apr 20;112(1):37-42
references.pmid: 2385361
references.citation: Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):659-78
references.pmid: 16741673
references.citation: J Neurosci. 1988 Oct;8(10):3785-96
references.pmid: 2903913
references.citation: Am J Physiol. 1991 Oct;261(4 Pt 2):R1028-38
references.pmid: 1928421
references.citation: J Neuroendocrinol. 1993 Jun;5(3):323-30
references.pmid: 8319005
references.citation: Brain Res. 1994 Jul 18;651(1-2):7-15
references.pmid: 7922591
references.citation: Neurosci Lett. 2004 Nov 11;370(2-3):252-6
references.pmid: 15488333
references.citation: J Neurosci. 1998 Jun 15;18(12):4705-21
references.pmid: 9614245
references.citation: Physiol Rev. 2001 Apr;81(2):629-83
references.pmid: 11274341
references.citation: Peptides. 2005 Dec;26(12):2629-711
references.pmid: 16039752
references.citation: Endocrinology. 1986 Oct;119(4):1558-63
references.pmid: 3019636
references.citation: J Comp Neurol. 1987 Jan 1;255(1):124-36
references.pmid: 3102567
references.citation: Endocr J. 1994 Dec;41(6):685-91
references.pmid: 7704093
references.citation: Nature. 1995 Nov 16;378(6554):287-92
references.pmid: 7477349
references.citation: Neuroendocrinology. 1986;43(4):519-25
references.pmid: 2427963
references.citation: Jpn J Physiol. 1998 Oct;48(5):301-31
references.pmid: 9852340
references.citation: J Neuroendocrinol. 2001 Jan;13(1):29-36
references.pmid: 11123513
references.citation: Nature. 1962 Dec 15;196:1109-10
references.pmid: 13995944
references.citation: Cell Mol Neurobiol. 2007 Aug;27(5):575-84
references.pmid: 17393298
references.citation: Endocrinology. 2004 Sep;145(9):4392-400
references.pmid: 15166125
references.citation: Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):703-18
references.pmid: 16897361
references.citation: Neuroscience. 1991;43(2-3):483-502
references.pmid: 1922780
references.citation: Clin Chim Acta. 2005 Jul 1;357(1):1-16
references.pmid: 15963791
references.citation: Int J Neurosci. 1992 Nov-Dec;67(1-4):241-70
references.pmid: 1305637
references.citation: Neuroendocrinology. 1987 Nov;46(5):439-44
references.pmid: 2893307
references.citation: Cell Mol Neurobiol. 2008 Feb;28(2):237-44
references.pmid: 17636405
references.citation: Curr Drug Targets. 2006 Aug;7(8):993-1003
references.pmid: 16918327
references.citation: J Hered. 1968 Mar-Apr;59(2):113-7
references.pmid: 5692127
references.citation: Neural Plast. 2000;7(3):179-91
references.pmid: 11147460
references.citation: Annu Rev Physiol. 1987;49:413-35
references.pmid: 3551809
references.citation: Med Sci (Paris). 2005 Aug-Sep;21(8-9):741-6
references.pmid: 16115460
references.citation: Peptides. 1986 Jul-Aug;7(4):609-13
references.pmid: 2429289
references.citation: J Autoimmun. 2008 Feb-Mar;30(1-2):84-9
references.pmid: 18191543
references.citation: Brain Res. 1985 Jul 8;338(1):81-9
references.pmid: 3896394
references.citation: Prog Neurobiol. 1999 Apr;57(6):625-55
references.pmid: 10221785
references.citation: Neuroscience. 1995 Oct;68(3):765-81
references.pmid: 8577372
references.citation: Brain Res. 1989 May 8;486(2):214-20
references.pmid: 2731031
references.citation: Neuroendocrinology. 1986;42(1):57-63
references.pmid: 3001564
references.citation: Nature. 1981 Feb 5;289(5797):502-4
references.pmid: 7007886
references.citation: Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):1047-55
references.pmid: 16625432
references.citation: Peptides. 2001 May;22(5):809-20
references.pmid: 11337095
references.citation: Recent Pat CNS Drug Discov. 2006 Nov;1(3):315-24
references.pmid: 18221213
references.citation: J Chem Neuroanat. 2002 Mar;23(3):171-86
references.pmid: 11861124
references.citation: Fukuoka Igaku Zasshi. 2001 Apr;92(4):89-98
references.pmid: 11411093
references.citation: Prog Neurobiol. 1995 Nov-Dec;47(4-5):291-339
references.pmid: 8966209
references.citation: Endocrinology. 1994 Nov;135(5):2058-63
references.pmid: 7956927
references.citation: Trends Pharmacol Sci. 2002 Oct;23(10):468-74
references.pmid: 12368071
references.citation: Arch Histol Cytol. 2001 Feb;64(1):37-44
references.pmid: 11310503
references.citation: Annu Rev Pharmacol Toxicol. 1988;28:123-40
references.pmid: 2898233
references.citation: Neuroscience. 1990;38(2):469-83
references.pmid: 2124666
references.citation: Brain Res. 1997 Aug 8;765(1):13-20
references.pmid: 9310389
references.citation: Trends Biochem Sci. 1991 Jan;16(1):27-30
references.pmid: 2053134
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7902-6
references.pmid: 7644511
references.citation: J Endocrinol. 1988 May;117(2):215-21
references.pmid: 3379355
references.citation: Lijec Vjesn. 1989 Sep-Oct;111(9-10):354-9
references.pmid: 2576679
references.citation: Am J Physiol. 1990 Feb;258(2 Pt 2):F397-402
references.pmid: 2137984
references.citation: Neuropeptides. 2001 Jun-Aug;35(3-4):162-7
references.pmid: 11884206
references.citation: J Comp Neurol. 1992 Dec 8;326(2):180-92
references.pmid: 1479074
references.citation: Brain Res Bull. 1983 Jan;10(1):163-6
references.pmid: 6824963
references.citation: Brain Res. 1990 Oct 29;531(1-2):299-303
references.pmid: 2126973
references.citation: Fiziol Zh Im I M Sechenova. 1996 Apr;82(4):65-9
references.pmid: 8963341
references.citation: Biochem Biophys Res Commun. 1989 Feb 28;159(1):317-23
references.pmid: 2538125
references.citation: Neuroscience. 1990;37(3):603-33
references.pmid: 1701038
references.citation: J Comp Neurol. 1992 Aug 15;322(3):439-48
references.pmid: 1517486
references.citation: J Comp Neurol. 1980 Dec 1;194(3):555-70
references.pmid: 7451682
references.citation: J Chem Neuroanat. 1996 Oct;11(4):243-56
references.pmid: 8951594
references.citation: Cell Mol Neurobiol. 2007 May;27(3):263-70
references.pmid: 17318383
references.citation: Neurosci Lett. 1988 Jul 19;90(1-2):45-50
references.pmid: 2457856
references.citation: Biochem J. 2001 Jul 1;357(Pt 1):241-7
references.pmid: 11415455
references.citation: Obes Rev. 2008 Jan;9(1):20-9
references.pmid: 17956545
references.citation: Neuroendocrinology. 1990 May;51(5):515-22
references.pmid: 2112729
references.citation: Cell Tissue Res. 1989 Feb;255(2):307-13
references.pmid: 2924334
references.citation: Neuroreport. 1997 Dec 22;8(18):3907-11
references.pmid: 9462464
references.citation: Neuroscience. 1989;29(2):371-83
references.pmid: 2725863
references.citation: J Comp Neurol. 1980 Jul 1;192(1):1-19
references.pmid: 7410605
references.citation: Pharmacol Ther. 2007 Aug;115(2):177-207
references.pmid: 17604107
references.citation: Neuroendocrinology. 1986;44(2):235-46
references.pmid: 3540701
references.citation: Cell Tissue Res. 1990 May;260(2):279-97
references.pmid: 1694105
references.citation: J Neuroendocrinol. 2001 Apr;13(4):328-38
references.pmid: 11264720
references.citation: Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):959-78
references.pmid: 16699879
references.citation: Peptides. 1985 May-Jun;6(3):421-5
references.pmid: 3840887
references.citation: Am J Physiol. 1984 Sep;247(3 Pt 2):F453-65
references.pmid: 6476123
references.citation: J Biol Chem. 2003 May 23;278(21):19280-5
references.pmid: 12639960
references.citation: J Neurochem. 2001 May;77(4):1085-96
references.pmid: 11359874
references.citation: Front Neuroendocrinol. 1997 Jul;18(3):292-353
references.pmid: 9237080
references.citation: Brain Res. 1990 May 14;516(1):41-5
references.pmid: 2364280
references.citation: Endocrinology. 1994 Apr;134(4):1635-9
references.pmid: 8137725
references.citation: J Neuroendocrinol. 2000 Sep;12(9):833-42
references.pmid: 10971808
references.citation: Brain Res. 1992 Feb 28;573(2):181-9
references.pmid: 1324077
references.citation: Brain Res. 1992 Nov 27;597(1):170-5
references.pmid: 1477732
references.citation: Regul Pept. 1991 Oct 29;36(2):197-218
references.pmid: 1805297
references.citation: Neuroendocrinology. 1999 Mar;69(3):167-80
references.pmid: 10087449
references.citation: Neuropharmacology. 2004;47 Suppl 1:274-85
references.pmid: 15464143
references.citation: J Neuroendocrinol. 2001 Apr;13(4):358-70
references.pmid: 11264724
references.citation: Proc Soc Exp Biol Med. 1997 May;215(1):1-10
references.pmid: 9142133
references.citation: Nucleic Acids Res. 1988 Dec 23;16(24):11811
references.pmid: 3211750
references.citation: Rev Port Cardiol. 2005 Oct;24(10):1263-76
references.pmid: 16398242
references.citation: Biochem Biophys Res Commun. 2007 Dec 7;364(1):60-5
references.pmid: 17927955
references.citation: Prog Brain Res. 2008;170:559-70
references.pmid: 18655909
references.citation: Curr Opin Endocrinol Diabetes Obes. 2007 Feb;14(1):63-7
references.pmid: 17940422
references.citation: Pain. 2008 Jul;137(1):41-49
references.pmid: 17884295
references.citation: Neurosci Lett. 1997 May 16;227(2):127-30
references.pmid: 9180220
references.citation: J Physiol. 1980 Nov;308:439-49
references.pmid: 7230026
references.citation: Neuroscience. 1992;48(3):669-80
references.pmid: 1376456
references.citation: Microsc Res Tech. 2002 Jan 15;56(2):81-91
references.pmid: 11810711
references.citation: Proc Nutr Soc. 1983 Jun;42(2):113-27
references.pmid: 6136974
references.citation: Horm Behav. 2007 Mar;51(3):395-405
references.pmid: 17258216
references.citation: Neurosci Lett. 2002 Jul 26;327(3):193-7
references.pmid: 12113910
references.citation: Neuropeptides. 1999 Oct;33(5):369-75
references.pmid: 10657514
references.citation: Curr Drug Targets. 2006 Aug;7(8):1031-42
references.pmid: 16918331
references.citation: Endocrinology. 2006 Feb;147(2):791-803
references.pmid: 16282358
references.citation: Am J Physiol. 1992 Jan;262(1 Pt 2):F17-23
references.pmid: 1733292